Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomized PROCTOR trial
Study context
- Population
- Patients with prior coronary artery bypass grafting (CABG) presenting with saphenous vein graft (SVG) failure and a clinical indication for revascularization, as determined by the local Heart Teamplanned
- Participants
- 584 patients
- Planned comparison
- Native vessel percutaneous coronary intervention (PCI) vs SVG PCI
- Primary endpoint
- MACE:
- All-cause mortality
- Non-fatal target coronary territory MI
- Clinically driven target coronary territory revascularization
- Follow-up
- 3 years
Methodological detailsrationale and design, prospective, multicentre, 1:1 randomisation, Follow-up invasive coronary angiography at 3 years, after evaluation of the primary endpoint
- Rationale and design
- Prospective
- Multicentre
- 1:1 randomisation
- Follow-up invasive coronary angiography at 3 years, after evaluation of the primary endpoint
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Percutaneous coronary intervention of native coronary artery versus saphenous vein graft in patients with prior coronary artery bypass graft surgery: Rationale and design of the multicenter, randomized PROCTOR trial. Am Heart J. Published 19 November 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →